홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Tetrabutylammonium → 5-{-4-[2-{-4-[6-(2-Cyclohexyl-ethoxy)-pyridazin-3-yl]-benzyl}-4-(2,4-dichloro-phenyl)-imidazol-1-yl]-phenyl}-1,2,5-thiadiazolidine-3-one-1,1-dioxide

HRID 1557193
인쇄

반응식

HRID 1557193 반응식
[CH3:59][CH2:60][CH2:61][CH2:62][N+:63]([CH2:64][CH2:65][CH2:66][CH3:67])([CH2:68][CH2:69][CH2:70][CH3:71])[CH2:72][CH2:73][CH2:74][CH3:75].[CH:1]1([CH2:7][CH2:8][O:9][c:10]2[cH:11][cH:12][c:13](-[c:16]3[cH:17][cH:18][c:19]([CH2:20][c:21]4[n:22](-[c:34]5[cH:35][cH:36][c:37]([N:40]6[CH2:41][C:42](=[O:55])[N:43]([CH2:47][O:48][CH2:49][CH2:50][Si:51]([CH3:52])([CH3:53])[CH3:54])[S:44]6(=[O:45])=[O:46])[cH:38][cH:39]5)[cH:23][c:24](-[c:26]5[c:27]([Cl:33])[cH:28][c:29]([Cl:32])[cH:30][cH:31]5)[n:25]4)[cH:56][cH:57]3)[n:14][n:15]2)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1.[F-:58]>>[CH:1]1([CH2:7][CH2:8][O:9][c:10]2[cH:11][cH:12][c:13](-[c:16]3[cH:17][cH:18][c:19]([CH2:20][c:21]4[n:22](-[c:34]5[cH:35][cH:36][c:37]([N:40]6[CH2:41][C:42](=[O:55])[NH:43][S:44]6(=[O:45])=[O:46])[cH:38][cH:39]5)[cH:23][c:24](-[c:26]5[c:27]([Cl:33])[cH:28][c:29]([Cl:32])[cH:30][cH:31]5)[n:25]4)[cH:56][cH:57]3)[n:14][n:15]2)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1
참가 물질출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 16028TetrabutylammoniumHCID 28179Fluoride IonHCID 685829705-{4-[2-{4-[6-(2-Cyclohexyl-ethoxy)-pyridazin-3-yl]benzyl}-4-(2,4-dichloro-phenyl)-imidazol-1-yl]-phenyl}-1,1-dioxo-2-(2-trimethylsilanyl-ethoxymethyl)-[1,2,5]thiadiazolidin-3-one

생성물 1

HCID 593055415-{-4-[2-{-4-[6-(2-Cyclohexyl-ethoxy)-pyridazin-3-yl]-benzyl}-4-(2,4-dichloro-phenyl)-imidazol-1-yl]-phenyl}-1,2,5-thiadiazolidine-3-one-1,1-dioxide

출처 및 근거

ORD 기록
ord-3de4e3c0ee7f419790be8b76a6decc77
출처 데이터셋
Training data from https://doi.org/10.1039/C8SC04228D (1/10)
DOI
10.1039/C8SC04228D

반응 노트

이 페이지에서참가 물질출처 및 근거반응 노트